Display options
Cite
Ly KI, Vakulenko-Lagun B, Emblem KE, et al. Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep. 2019;9(1):8721doi: 10.1038/s41598-019-44365-2.
Ly, K. I., Vakulenko-Lagun, B., Emblem, K. E., Ou, Y., Da, X., Betensky, R. A., Kalpathy-Cramer, J., Duda, D. G., Jain, R. K., Chi, A. S., Plotkin, S. R., Batchelor, T. T., Sorensen, G., Rosen, B. R., & Gerstner, E. R. (2019). Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Scientific reports, 9(1), 8721. https://doi.org/10.1038/s41598-019-44365-2
Ly, K Ina, et al. "Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI." Scientific reports vol. 9,1 (2019): 8721. doi: https://doi.org/10.1038/s41598-019-44365-2
Ly KI, Vakulenko-Lagun B, Emblem KE, Ou Y, Da X, Betensky RA, Kalpathy-Cramer J, Duda DG, Jain RK, Chi AS, Plotkin SR, Batchelor TT, Sorensen G, Rosen BR, Gerstner ER. Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep. 2019 Jun 14;9(1):8721. doi: 10.1038/s41598-019-44365-2. PMID: 31197238; PMCID: PMC6565804.
Copy Download .nbib Format: NLM
Share it on

Sci Rep. 2019 Jun 14;9(1):8721. doi: 10.1038/s41598-019-44365-2.

Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.

Scientific reports

K Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, Yangming Ou, Xiao Da, Rebecca A Betensky, Jayashree Kalpathy-Cramer, Dan G Duda, Rakesh K Jain, Andrew S Chi, Scott R Plotkin, Tracy T Batchelor, Gregory Sorensen, Bruce R Rosen, Elizabeth R Gerstner

Affiliations

  1. Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  2. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  3. Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  4. Department of Pediatrics and Radiology, Boston Children's Hospital, Boston, MA, USA.
  5. Functional Neuroimaging Laboratory, Brigham and Women's Hospital, Boston, MA, USA.
  6. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.
  7. Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  8. Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.
  9. IMRIS, Deerfield Imaging, Minnetonka, MN, USA.
  10. Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. [email protected].

PMID: 31197238 PMCID: PMC6565804 DOI: 10.1038/s41598-019-44365-2

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Publication Types